Clinical Trial: An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Crohn's Disease
Study Type: OBSERVATIONAL
Official Title: Patient-reported Real-world Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in the UK: a Before-and-after Survey of Participants Among Patients That Transit
Brief Summary:
Crohn's Disease (CD) is a chronic condition that causes inflammation of the gastrointestinal tract or gut.This study will assess real-world, adult participant experience of self-injection with the risankizumab OBI.Risankizumab is an approved drug for the treatment of CD in adults.Approximately 80 participants who are prescribed risankizumab by their doctors and are transitioning from the pre-filled syringe (PFS) to the use of OBI will be enrolled in this study in the United Kingdom (UK).Participants will…
Read more